ELAMIPRETIDE IN PATIENTS WITH BARTH SYNDROME: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL FOLLOWED BY 36-WEEK OPEN-LABEL EXTENSION
Authors:
- Reid ThompsonRTReid Thompson
- Ryan ManuelRMRyan Manuel
- Anthony AiudiAAAnthony Aiudi
- John J. JonesJJJohn J. Jones
- Jim CarrJCJim Carr
- Brittany HornbyBHBrittany Hornby
- Hilary VernonHVHilary Vernon